Combining Awareness and Innovation
Jared Baeten, Vice President, Clinical Development, HIV Franchise Head at Gilead Sciences highlights how awareness and clinical innovation have transformed research in the HIV space.
Jared Baeten, Vice President, Clinical Development, HIV Franchise Head at Gilead Sciences discusses how he chose to focus his career path on HIV research and how increased awareness combined with new innovations have advanced the therapeutic area. He also touches on the operational challenges he is currently seeing within HIV trials.
About the Speaker
Outside of his current role with Gilead, which he started in 2020, Jared is also a professor/affiliate professor at the University of Washington in the departments of global health, medicine, and epidemiology. He has been with the university for over 17 years and has also served as a vice chair, vice dean, associate professor, assistant professor, and senior fellow.
About the ACT Podcast
The editors of Applied Clinical Trials bring you the latest commercial insights to master the science of success. Podcast episodes examine current trends, key conferences, and critical topics in the bio/pharmaceutical industry.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
